Activation of phospholipase A2 by prostaglandin in vitro

Strong, 1967, Effects of prostaglandins E1 E2 A1 and F1alpha on isolated vascular smooth muscle, Am. J. Physiol., 213, 725, 10.1152/ajplegacy.1967.213.3.725 Holmes, 1963, Effect of prostaglandin E1 on responses of smooth muscle to catechol amines, angiotensin and vasopressin, Br. J. Pharmacol., 21, 538 Christ, 1972, Comparative aspects of prostaglandin biosynthesis in animal tissues, Biochim. Biophys. Acta, 270, 537, 10.1016/0005-2760(72)90119-1 Ribardo, 2001, Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D, J. Biol. Chem., 276, 5467, 10.1074/jbc.M006690200 Straus, 2001, Cyclopentenone prostaglandins: new insights on biological activities and cellular targets, Med. Res. Rev., 21, 185, 10.1002/med.1006 Piper, 1971, The release of prostaglandins from lung and other tissues, Ann. N. Y. Acad. Sci., 180, 363, 10.1111/j.1749-6632.1971.tb53205.x Zia, 1975, A radioimmunoassay for prostaglandin A1 in human peripheral blood, J. Clin. Endocrinol. Metab., 41, 245, 10.1210/jcem-41-2-245 Golub, 1975, Metabolism of prostaglandins A1 and E1 in man, J. Clin. Invest., 56, 1404, 10.1172/JCI108221 Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase, Nature, 403, 103, 10.1038/47520 Mandal, 2005, Yin-yang: balancing act of prostaglandins with opposing functions to regulate inflammation, J. Immunol., 175, 6271, 10.4049/jimmunol.175.10.6271 Kato, 1986, Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo, Cancer Res., 46, 3538 Perez-Sala, 2002, Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins, Ann. N. Y. Acad. Sci., 973, 533, 10.1111/j.1749-6632.2002.tb04695.x Fukushima, 1990, Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved, Eicosanoids, 3, 189 Garzon, 2010, A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification, Chem. Biol. Interact., 183, 212, 10.1016/j.cbi.2009.09.019 Rossi, 1997, Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation, Proc. Natl. Acad. Sci. U. S. A., 94, 746, 10.1073/pnas.94.2.746 Diez-Dacal, 2016, Molecular interactions and implications of aldose reductase inhibition by PGA1 and clinically used prostaglandins, Mol. Pharmacol., 89, 42, 10.1124/mol.115.100693 Shiraki, 2005, alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor, J. Biol. Chem., 280, 14145, 10.1074/jbc.M500901200 Perez-Sala, 2003, Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta(12,14)-prostaglandin J(2), J. Biol. Chem., 278, 51251, 10.1074/jbc.M309409200 Pieterson, 1974, Zymogen-catalyzed Hydrolysis of monomeric substrates and presence of a recognition site for lipid-water interfaces in Phospholipase-A2, Biochemistry, 13, 1455, 10.1021/bi00704a021 Verger, 1973, Action of phospholipase a at interfaces, J. Biol. Chem., 248, 4023, 10.1016/S0021-9258(19)43833-7 Wells, 1974, The mechanism of interfacial activation of phospholipase A2, Biochemistry, 13, 2248, 10.1021/bi00708a002 Wells, 1978, Interfacial activation of phospholipase A2, Adv. Prostaglandin Thromboxane Res., 3, 39 Code, 2008, Amyloid-type fiber formation in control of enzyme action: interfacial activation of phospholipase A2, Biophys. J., 95, 215, 10.1529/biophysj.108.128710 Massimino, 2018, Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A 2 and mediates its toxic activity, Sci. Rep., 13, 1 Tejera-Garcia, 2012, Gravimetric determination of phospholipid concentration, Chem. Phys. Lipids, 165, 689, 10.1016/j.chemphyslip.2012.06.005 Bell, 1989, The temporal sequence of events in the activation of phospholipase A2 by lipid vesicles. Studies with the monomeric enzyme from Agkistrodon piscivorus piscivorus, J. Biol. Chem., 264, 12194, 10.1016/S0021-9258(18)63840-2 Code, 2009, Activation of phospholipase A2 by temporin B: formation of antimicrobial peptide-enzyme amyloid-type cofibrils, Biochim. Biophys. Acta, 1788, 1064, 10.1016/j.bbamem.2009.03.002 Thuren, 1988, Phospholipase-A2 assay using an intramolecularly quenched pyrene-labeled phospholipid analog as a substrate, Anal. Bioch., 170, 248, 10.1016/0003-2697(88)90115-7 Thuren, 1987, Hydrolysis of 1-palmitoyl-2-[6-(pyren-1-yl)]hexanoyl-sn-glycero- 3-phospholipids by phospholipase A2: effect of the polar head-group, Biochim. Biophys. Acta, 917, 411, 10.1016/0005-2760(87)90120-2 Sanchez, 2002, A two-photon view of an enzyme at work: crotalus atrox venom PLA2 interaction with single-lipid and mixed-lipid giant unilamellar vesicles, Biophys. J., 82, 2232, 10.1016/S0006-3495(02)75569-0 Honger, 1994 Hoyrup, 2001 Gharbi, 2007, Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin, J. Mass Spectrom., 42, 1474, 10.1002/jms.1291 Gayarre, 2005, Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione, FEBS Lett., 579, 5803, 10.1016/j.febslet.2005.09.069 Mattila, 2008, Oxidized phospholipids as potential molecular targets for antimicrobial peptides, Biochim. Biophys. Acta-Biomembranes, 1778, 2041, 10.1016/j.bbamem.2008.03.020 Code, 2010, Activation of phospholipase A2 by 1-palmitoyl-2-(9’-oxo-nonanoyl)-sn-glycero-3-phosphocholine in vitro, Biochim. Biophys. Acta, 1798, 1593, 10.1016/j.bbamem.2010.05.002 Ghomashchi, 1998, Interfacial recognition by bee venom phospholipase A(2): insights into nonelectrostatic molecular determinants by charge reversal mutagenesis, Biochem., 37, 6697, 10.1021/bi972525i Scott, 1990, Crystal-structure of bee-venom Phospholipase-A2 in a complex with a transition-state analog, Science, 250, 1563, 10.1126/science.2274788 Lin, 1998, Binding of bee venom and human group IIa phospholipases A2 to membranes: a minor role for electrostatics, Biochem. Soc. Trans., 26, 341, 10.1042/bst0260341 Pasha, 2012, Mass spectrometry analysis of modified bee venom phospholipase A(2) in correlation with increased activity, Free Radic. Biol. Med., 53, S213, 10.1016/j.freeradbiomed.2012.08.447 Welker, 2011, Disulfide bonds of phospholipase A2 from bee venom yield discrete contributions to its conformational stability, Biochimie, 93, 195, 10.1016/j.biochi.2010.09.012 Mahalka, 2011, Activation of phospholipase A2 by Hsp70 in vitro, Biochim. Biophys. Acta, 1808, 2569, 10.1016/j.bbamem.2011.06.002 Bell, 2003, Liposomes in the study of phospholipase a2 activity, Vol. 372, 19 Lehtonen, 1995, Phospholipase A2 as a mechanosensor, Biophys. J., 68, 1888, 10.1016/S0006-3495(95)80366-8 Tajuddin, 2014, Neuroinflammation and neurodegeneration in adult rat brain from binge ethanol exposure: abrogation by docosahexaenoic acid, PLoS One, 9, 10.1371/journal.pone.0101223 Kanai, 1995, Identification and characterization of a prostaglandin transporter, Science, 268, 866, 10.1126/science.7754369 Courregelongue, 2001, Interactions Between Antiviral Prostaglandins and Biomimetic Membranes: A Langmuir films study, J. Therm. Anal. Calorim., 63, 47, 10.1023/A:1010172016874 Sorokina, 1990, Change in the structure and permeability of phosphatidylcholine membranes stimulated by prostaglandins, Bioelectrochem. Bioenerg., 23, 271, 10.1016/0302-4598(90)80016-C Kury, 1974, The effect of prostaglandins E1 and E2 on the human erythrocyte as monitored by spin labels, Biochem. Biophys. Res. Commun., 56, 478, 10.1016/0006-291X(74)90867-5 Grimsrud, 2008, Oxidative stress and covalent modification of protein with bioactive aldehydes, J. Biol. Chem., 283, 21837, 10.1074/jbc.R700019200 Higdon, 2012, Cell signalling by reactive lipid species: new concepts and molecular mechanisms, Biochem. J., 442, 453, 10.1042/BJ20111752 Stadtman, 2006, Protein oxidation and aging, Free Radic. Res., 40, 1250, 10.1080/10715760600918142 Wong, 2010, Methionine oxidation induces amyloid fibril formation by full-length apolipoprotein A-I, Proc. Natl. Acad. Sci. U. S. A., 107, 1977, 10.1073/pnas.0910136107 Kurouski, 2014, Is supramolecular filament chirality the underlying cause of major morphology differences in amyloid fibrils?, J. Am. Chem. Soc., 136, 2302, 10.1021/ja407583r Trovato, 2006, Insight into the structure of amyloid fibrils from the analysis of globular proteins, PLoS Comput. Biol., 2, e170, 10.1371/journal.pcbi.0020170 Mahalka, 2013, Class specific peptide inhibitors for secretory phospholipases A2, Biochem. Biophys. Res. Commun., 436, 349, 10.1016/j.bbrc.2013.05.110 Ahmed, 2010, Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils, Nat. Struct. Mol. Biol., 17, 561, 10.1038/nsmb.1799 Nasstrom, 2011, The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of alpha-synuclein oligomers with distinct biochemical, morphological, and functional properties, Free Radic. Biol. Med., 50, 428, 10.1016/j.freeradbiomed.2010.11.027 Bazan, 2002, Prostaglandins and other lipid mediators in Alzheimer’s disease, Prostaglandins Other Lipid Mediat., 68, 197, 10.1016/S0090-6980(02)00031-X Prasad, 1998, Prostaglandins as putative neurotoxins in Alzh eimer’s disease, Exp. Biol. Med., 219, 120, 10.3181/00379727-219-44323 Prasad, 1998, Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and β-amyloid, In Vitro Cell. Dev. Biol. Anim., 34, 265, 10.1007/s11626-998-0133-7 Boutaud, 2002, Prostaglandin H2 (PGH2) accelerates formation of amyloid β1− 42 oligomers, J. Neurochem., 82, 1003, 10.1046/j.1471-4159.2002.01064.x Koharudin, 2010, Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1, Proc. Natl. Acad. Sci. U. S. A., 107, 6835, 10.1073/pnas.1002295107 Breyer, 2001, Prostanoid receptors: subtypes and signaling, Annu. Rev. Pharmacol. Toxicol., 41, 661, 10.1146/annurev.pharmtox.41.1.661 Straus, 2000, 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway, Proc. Natl. Acad. Sci. U. S. A., 97, 4844, 10.1073/pnas.97.9.4844 Oeste, 2014, Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function, Mass Spectrom. Rev., 33, 110, 10.1002/mas.21383